Health And Medicine

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States. Read More

By Aaron Conley Systems biology and the Lopez lab The history of hermeneutics started with Aristotle—parts comprise the whole. To understand the whole, we need to understand the parts. And to understand the parts, we need to understand them in the context of the whole. Carlos F. Lopez, associate… Read More

Join taste experts, scientists and a Nashville chef to learn about the science behind flavor in a virtual event on Monday, Jan. 31, at noon CT. Read More

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. Read More

Dr. William Schaffner, an internationally renowned infectious disease specialist and public health expert, shares what you should know about the latest COVID-19 variant wave, including information about breakthrough symptoms for the vaccinated population. Read More

A team of Vanderbilt researchers led by Ken Lau has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Read More

Lars Plate wins $55,000 from Scialog to further collaborative research on cell behavior. Read More

Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Read More

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read More

Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read More

There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read More

Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read More

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read More

The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read More

John McLean, Stevenson Professor of Chemistry and director of the Center for Innovative Technologies, has been elected a 2021 fellow of the National Academy of Inventors.  Read More

Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read More

Dr. Sophie Katz, assistant professor of pediatric infectious diseases and associate medical director of the Pediatric Antimicrobial Stewardship Program, describes the symptoms and treatment of multisystem inflammatory syndrome in children (MIS-C). Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read More

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read More

Erin Calipari, assistant professor of pharmacology and a member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. Read More